期刊文献+

真菌菌群在肠道疾病中的作用进展 被引量:15

The development of fungal community in intestinal diseases
下载PDF
导出
摘要 肠道菌群对人体能量代谢、肠道功能、免疫系统、治疗糖尿病等方面具有重要作用。肠道定植真菌菌群虽在肠道菌群中所占比例极少,但对肠道菌群内稳态平衡的维持作用显著。真菌菌群不仅通过细胞壁上的多种抗原复合物激活人体先天性和获得性免疫反应,而且还参与促进肠系膜和肠道周围免疫淋巴系统的成熟,涉及多系统性疾病(如肠易激综合征、消化性溃疡、肿瘤、乙型肝炎、侵袭性肺炎和冠状动脉粥样硬化症等)的病理生理过程。肠道真菌菌群在肠道疾病中的重要作用正逐渐得到关注。以下将对其在菌群失调相关性腹泻和炎性肠病中的关键作用作一综述。 The abnormal intestinal fungal community has been associated with multisystem diseases,such as antibiotic-associated diarrhea( AAD),inflammatory bowel disease( IBD) and atherosclerosis et al. But compared to the bacterial community,the knowledge regarding to fungal community is still limited. The fungal community is rare in whole microflora while it does matter to maintain the balance of gut microflora. It participates in many nature and nurture immunoreactions,promotes the mature of mesenteric and mucosal immune system. In this review,special attention were paid to the effect of abnormal fungal community in antibiotic-associated diarrhea and inflammatory bowel disease.
出处 《肠外与肠内营养》 北大核心 2015年第6期378-381,共4页 Parenteral & Enteral Nutrition
关键词 真菌菌群 肠道微生物 炎性肠病 菌群失调相关性腹泻 Fungal community Intestinal microflora Inflammatory bowel disease Antibiotic-associated diarrhea
  • 相关文献

参考文献35

  • 1Wang ZK, Yang YS, Stetka AT, et aI. Review article : fungal mi- crobiota and digestive diseases. Alimentary Pharmacology & Ther- apeutics,2014,39 (8) :751-766.
  • 2Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature, 2010, 464 (7285) :59-65.
  • 3Rohde CL,Bartolini V,Jones N. The use of probioties in the pre- vention and treatment of antibiotic-associated diarrhea with spe- cial interest in Clostridium diffieile-associated diarrhea. Nutrition in Clinical Practice:Official Publication of the American Society for Parenteral and Enteral Nutrition,2009,24 ( 1 ) : 33-40.
  • 4Scupham A J, Presley LL, Wei B, et al. Abundant and diverse fun- gal microbiota in the murine intestine. Applied and Environmental Microbiology, 2006,72 ( 1 ) : 793-801.
  • 5Frey KP, Burlinson P, Deveau A, et al. Bacterial-fungal interac- tions : hyphens between agricultural, clinical, environmental, and food microbiologists. Microbiology and Molecular Biology Re- views ,2011,75 (4) :583-609.
  • 6Noverr MC, Huffnagle GB. Regulation of Candida albicans mor- phogenesis by fatty acid metabolites. Infection and Immunity, 2004,72( 11 ) :6206-6210.
  • 7Wagner RD, Pierson C, Warner T, et al. Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice. Infec- tion and Immunity, 1997,65 ( 10 ) :4165 -4172.
  • 8Hummel RP, Oestreicher E J, Maley MP, et al. Inhibition of Candi- da albicans by Escherichia coli in vitro and in the germfree mouse. The Journal of Surgical Research, 1973,15 ( 1 ) :53-58.
  • 9Rosenbach A, Dignard D, Pierce JV, et al. Adaptations of Candida albicans for growth in the mammalian intestinal tract. Eukaryotic Cell,2010,9 (7) : 1075-1086.
  • 10Noverr MC, Noggle RM, Toews GB, et al. Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infec- tion and Immunity,2004,72(9) :4996-5003.

二级参考文献1

共引文献38

同被引文献145

引证文献15

二级引证文献145

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部